Joseph P Slattery has bought stock on 4 days since May 2016
Director at ImageneBio, Inc., and 3 other companies
SEC CIK 0001246530 · Filings on SEC.gov ↗
Joseph P Slattery's record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Companies
Every filing
13 filings since May 2016, newest first
Imagenebio, Inc.
Director
Replimune Group, Inc.
Director
Morphic Holding, Inc.
Director
Transenterix Inc.
EVP and CFO
Transenterix Inc.
EVP and CFO
Transenterix Inc.
EVP and CFO
Replimune Group, Inc.
Director
Transenterix Inc.
EVP and CFO
Transenterix Inc.
EVP and CFO
Transenterix Inc.
EVP and CFO
Transenterix Inc.
EVP and CFO
Transenterix Inc.
EVP and CFO
Transenterix Inc.
EVP and CFO
About Joseph P Slattery
Joseph P. Slattery is a seasoned finance executive and corporate director serving as a Director at Imagenebio, Inc. (IMA, formerly IKNA), where he has recently engaged in insider trading activities.( He holds or has held director positions at multiple public companies, including Morphic Holding, Inc. (MORF), Asensus Surgical, Inc. (TRXC, formerly TransEnterix where he served as EVP & CFO), Replimune Group, Inc., and CVRx, Inc., where he is Lead Independent Director.(
Slattery is a Certified Public Accountant (CPA) and member of the Virginia Society of CPAs, with a history of insider trading across at least seven companies, including Digene Corp.( His estimated net worth from reported holdings ranges from $829,256 to $9.49 million as of late 2025.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.